REAL-WORLD DATA AS EXTERNAL CONTROLS FOR SINGLE-ARM TRIALS: ROLE IN REGULATORY AND HEALTH TECHNOLOGY ASSESSMENTS

被引：0
|
作者：
Tomeczkowski, J. [1 ]
Partemio, G. [2 ]
Nijhuis, T. [3 ]
Kubitz, N. [1 ]
Kavanagh, S. [4 ]
机构：
[1] Janssen Cilag GmbH, Neuss, Germany
[2] IQVIA Ltd, London, England
[3] IQVIA, Amsterdam, Netherlands
[4] Janssen Pharmaceut NV, Beerse, Belgium
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HTA24
引用
收藏
页码：S300 / S301
页数：2
相关论文
共 50 条
  • [1] Use of quantitative bias analysis to evaluate single-arm trials with real-world data external controls
    Gray, Christen
    Ralphs, Eleanor
    Fox, Matthew P.
    Lash, Timothy L.
    Liu, Geoffrey
    Kou, Tzuyung Doug
    Rivera, Donna R.
    Bosco, Jaclyn
    Braun, Kim Van Naarden
    Grimson, Fiona
    Layton, Deborah
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (05)
  • [2] COMPARATIVE EFFECTIVENESS USING EXTERNAL CONTROLS FOR SINGLE-ARM TRIALS OF PEMBROLIZUMAB IN TUMOR-AGNOSTIC INDICATIONS LEVERAGING REAL-WORLD DATA
    Chen, Y.
    Martin, P.
    Ye, S.
    Inoue, L.
    Basu, A.
    Carlson, J. J.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S363 - S364
  • [3] HEALTH TECHNOLOGY ASSESSMENTS OF SINGLE-ARM CLINICAL TRIALS IN GERMANY AND FRANCE
    Heidbrede, T.
    Basic, E.
    Bussilliat, P.
    Dintsios, C. M.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S347 - S347
  • [4] Informing single-arm clinical trials with external controls
    Ruthie Davi
    Nirosha Mahendraratnam
    Arnaub Chatterjee
    C. Jill Dawson
    Rachel Sherman
    [J]. Nature Reviews Drug Discovery, 2020, 19 : 821 - 822
  • [5] Informing single-arm clinical trials with external controls
    Davi, Ruthie
    Mahendraratnam, Nirosha
    Chatterjee, Arnaub
    Dawson, C. Jill
    Sherman, Rachel
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (12) : 821 - 822
  • [6] Single-arm oncology trials and the nature of external controls arms
    Hashmi, Mustafa
    Rassen, Jeremy
    Schneeweiss, Sebastian
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 10 (12) : 1053 - 1066
  • [7] EVALUATION OF REAL-WORLD EVIDENCE (RWE) USED WITHIN HEALTH TECHNOLOGY ASSESSMENTS (HTA) IN ONCOLOGY WITH PIVOTAL SINGLE-ARM TRIALS: A COMPARATIVE STUDY OF SIX HTA AGENCIES
    Harricharan, S.
    Gurjar, K.
    Nguyen, K.
    Forsythe, A.
    [J]. VALUE IN HEALTH, 2021, 24 : S51 - S51
  • [8] Regulatory and HTA Considerations for Development of Real-World Data Derived External Controls
    Curtis, Lesley H.
    Sola-Morales, Oriol
    Heidt, Julien
    Saunders-Hastings, Patrick
    Walsh, Laura
    Casso, Deborah
    Oliveria, Susan
    Mercado, Tiffany
    Zusterzeel, Robbert
    Sobel, Rachel E.
    Jalbert, Jessica J.
    Mastey, Vera
    Harnett, James
    Quek, Ruben G. W.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (02) : 303 - 315
  • [9] Enriching single-arm clinical trials with external controls: possibilities and pitfalls
    Lambert, Jerome
    Lengline, Etienne
    Porcher, Raphael
    Thiebaut, Rodolphe
    Zohar, Sarah
    Chevret, Sylvie
    [J]. BLOOD ADVANCES, 2023, 7 (19) : 5680 - 5690
  • [10] A novel approach to augment single-arm clinical studies with real-world data
    Sachdeva, Archie
    Tiwari, Ram C.
    Guha, Subharup
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2022, 32 (01) : 141 - 157
12345